StemTech Of Malaysia Automates Adult Stem-Cell Harvesting
This article was originally published in PharmAsia News
Malaysia's StemTech International became the first biotech in Southeast Asia to establish an automated processing technology system for harvesting adult stem cells and cord blood. The company said it had obtained the U.S.-made FACSCAlibur Cytometer for higher stem-cell yield, allowing for a higher survival rate in transplantation. The cytometer is capable of producing CD34 cell analysis and testing for cell viability. (Click here for more
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.